Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-01-18
2005-01-18
McKelvey, Terry (Department: 1636)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S209100
Reexamination Certificate
active
06843996
ABSTRACT:
Recombinant PB2 variant influenza viruses, RNA, cDNA and vectors are provided. Also provided are immunogenic compositions containing the variant viruses, methods of producing such viruses and methods for the prophylactic treatment of influenza in humans.
REFERENCES:
patent: WO 9508634 (1995-03-01), None
Akkina et al. (1987) “Intracellular Localization of Viral Polymerase Proteins in Cells Infected with Influenza Virus and Cells Expression PB Protein from Cloned cDNA.”Journal of Virology61(7):2217-2224.
Barclay and Palese (1995) “Influenza B Virus with Site-Specific Mutations Introduced into the HA Gene.”Journal of Virology69(2): 1275-1279.
Bass et al. (1991) “A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor.”Proceedings of the National Academy of Sciences, USA88:4498-4502.
Baylor et al. (1988) “Transient Expression and Sequence of the Matrix (M1) Gene of WSN Influenza A Virus in a Vaccinia Vector.”Virology163:618-621.
Buckler-White et al. (1986) “Characterization of a Gene Coding for M Proteins Which Is Involved in Host Range Restriction of an Avian Influenza A Virus in Monkies.”Journal of Virology57(2): 697-700.
Clements et al. (1992) “Use of Single-Gene Ressortant Viruses to Study the Role of Avian Influenza A Virus Genes in Attenuation of Wild-Type Human Influenza A Virus for Squirrel Monkeys and Aduld Human Volunteers.”Journal of Clinical Microbiology30(3): 655-662.
Cox et al. (1988) “Identification of Sequence Changes in the Cold-Adapted, Live Attenuated Influenza Vaccine Strain, A/Ann Arbor/6/60 (H2N2).”Virology167:554-567.
De La Luna et al. (1989) “Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains.”Virus Research13:143-156.
Diamond and Kirkegaard (1994) “Clustered Charged-to-Alaine Mutagenesis of Poliovirus RNA-Dependent RNA Polymerase Yeilds Multiple Temperaturs-Sensitive Muntants Defective in RNA Synthesis.”Journal of Virology68(2): 863-876.
Enami and Palese (1991) “High-Efficiency Formation of Influenza Virus Transfectants.”Journal of Virology65(5): 2711-2713.
Enami et al. (1990) “Introduction of site-specific mutations into the genome of influenza virus.”Proceedings of the National Academy of Sciences, USA87:3802-3805.
Gorman et al. (1990) “Evolution of Influenza A Virus PB2 Genes: Implication for Evolution of the Ribnucleoprotein Complex and Origin of Human Influenza A Virus.”Journal of Virology64(10): 4893-1902.
Hassett and Condit (1994) “Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine.”Proceedings of the National Academy of Sciences, USA91:4554-4558.
Herlocher et al. (1993) “Molecular and biological changes in the cold-adapted ‘master strain’ A/AA/6/60 (H2N2) influenza virus.”Proceedings of the National Academy of Sciences, USA. 6032-6036.
Horimoto and Kawaoka (1994) “Reverse Geneitcs Provides Direct Evidence for a Correlation of Hemagglutinin Cleavability and Virulence of an Avian Influenza A Virus.”Journal of Virology68(5): 3120-3128.
Lawson et al. (1992) Nucleotide Sequence Changes in the Polymerase Basic Protein 2 Gene of Temperature-Sensitive Mutants of Influenza A Virus.Virology191:506-510.
Li et al. (1992) “Influenza A Virus Transfectants with Chimeric Hemagglutinins Containing Epitopes from Different Subtypes.”Journal of Virology66(1): 399-404.
Luytjes et al. (1989) “Amplification, Expression, and Packing of a Foreign Gene by Influenza Virus.”Cell59: 1107-1113.
Markushin et al. (1988) “Nucleotide sequence of RNA segment 7 and the predicted amino sequence of M1 and M2 proteins of FPV/Weybridge (H7N7) and WSN (H1N1) influenza viruses.”Virus Research10:263-272.
McCauley and Penn (1990) “The critical cut-off temperature of avian influenza viruses.”Virus Research17:191-198.
Mukaigawa and Nayak (1991) “Two Signals Mediate Nuclear Localization of Influenza Virus (A/WSN/33) Polymerase Basic Protein 2.”Journal of Virology65(1): 245-253.
Murphy (1993) Use of Live Attenuated Cold-Adapted Influenza A Reassortant Virus Vaccines in Infants, Children, Young Adults, and Elderly Adults.Infectious Diseases in Clinical Practice2:174-181.
Murphy and Chanock (1981) “Genetic Approaches to the Prevention of Influenza A Virus Infection.”Genetic Variation Among Influenza Viruses600-614.
Murphy et al. (1980) “Escape of A Highly Defective Influenza A Virus Mutant From Its Temperature Sensitive Phenotype by Extragenic Suppression and Other Types of Mutation.”Annals NY Acad. Scipp. 172-182.
Murphy et al. (1980) “Genetic Approaches to Attenuation of Influenza A Virus for Man.”Philosophical Transactions of the Royal Society of London, Series B 288:401-415.
Nakagawa et al. (1995) “The RNA Polymerase PB2 Subunit Is Not Required for Replication of the Influenza Virus Genome but is Involved in Capped mRNA Synthesis.”Journal of Virology69(2): 728-733.
Nieto et al. (1994) “Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit.”Journal of Virology75:29-36.
Schonberger et al. (1981) “Guillain-Barre syndrome: its epidemiology and association with influenza vaccination.”Annals of Neurology9 Suppl: 31-38 ABSTRACT.
Shu et al. (1993) “Analysis of the Evolution and Variation of the Human Influenza A Virus Nucleoprotein Gene from 1933 to 1990.”Journal of Virology67(5): 2723-2729.
Snyder et al. (1988) Four Viral Genes Independently Contribute to Attenuation of Live Influenza A/Ann Arbor/6/60 (H2N2) Cold-Adapted Reassortant Virus Vaccines.Journal of Virology62(2): 488-495.
Subbarao et al. (1993) “Rescue of an Influenza A Virus Wild-Type PB2 Gene and a Mutant Derivative Bearing a Site-Specific Temperaturs-Sensitive and Attenuating Mutation.”Journal of Virology67(12): 7223-7228.
Tolpin et al. (1982) “Evaluation of a Phenotype Revertant of the A/Alaska/77-ts-1A2 Ressortant Virus in Hamsters and in Seronegative Adult Volunteers: Further Evidence that the Temperature-Sensitive Phenotype Is Responsible for Attenuation of ts-1A2 Ressortant Viruses.”Infection and Immunity36(2): 645-650.
Wertman et al. (1992) “Systematic Mutation Analysis of the Yeast ACT1 Gene.”Genetics132:337-350.
Wiskerchen and Muesing (1995) “Identification and Characterization of a Temperature-Sensitive Mutant of Human Immunodeficiency Virus Type 1 by Alanine Scanning Mutagenesis of the Integrase Gene.”Journal of Virology69(1): 579-601.
Yamanaka et al. (1990) “Characterization of a temperature-sensitive mutant in the RNA Polymerase PB2 subunit gene of influenza A/WSN/33 virus.”Arch Virol114:65-73.
Yasuda et al. (1994) “Growth Control of Influenza A Virus by M1 Protein: Analysis of Transfectant Viruses Carrying the Chimeric M Gene.”Journal of Virology68(12): 8141-8146.
Parkin et al. (1996) Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alanine mutagenesis.Virus Research46(1-2):31-44.
Parkin et al. (1996) “Genetically engineered temperature-sensitive, attenuated mutants of influenza A virus: clustered charged-to-alanine mutants in PB2.”Int. Congr. Ser. pp. 788-794.
Coelingh Kathleen L.
Parkin Neil T.
McKelvey Terry
Medimmune Vaccines, Inc.
Medimmune, Inc.
LandOfFree
Immunogenic composition comprising an influenza virus with a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic composition comprising an influenza virus with a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic composition comprising an influenza virus with a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3389109